Regorafenib N-oxide and N-desmethyl (M5)-¹³C₆

Cat. No.: HY-108226S1: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

Regorafenib N-oxide and N-desmethyl (M5)-¹³C₆ is the ¹³C-labeled Regorafenib N-oxide and N-desmethyl (M5)[1].

For research use only. We do not sell to patients.

Regorafenib N-oxide and N-desmethyl (M5)-<sup>13</sup>C<sub>6</sub> Chemical Structure

Regorafenib N-oxide and N-desmethyl (M5)-¹³C₆ Chemical Structure

Size		Stock
1 mg		Get quote	Estimated Time of Arrival: December 31

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of Regorafenib N-oxide and N-desmethyl (M5)-¹³C₆:

Regorafenib N-oxide and N-desmethyl (M5)-d₃ Get quote

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

Regorafenib N-oxide and N-desmethyl (M5)-¹³C₆ is the ¹³C-labeled Regorafenib N-oxide and N-desmethyl (M5)[1].

In Vitro

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

490.74

Formula

C₁₄¹³C₆H₁₃ClF₄N₄O₄

Unlabeled CAS

835621-12-0

Appearance

Solid

Color

White to off-white

SMILES

O=C(C1=CC(OC2=CC=C(C(F)=C2)NC(N[13C]3=[13CH][13CH]=[13C]([13C](C(F)(F)F)=[13CH]3)Cl)=O)=CC=[N+]1[O-])N

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Purity & Documentation

Purity: ≥91.0%

Select Batch:

Data Sheet (264 KB) SDS (251 KB)

COA (244 KB)

Handling Instructions (2659 KB)

References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. [Content Brief]